Zacks Investment Research Shares of SurModics (SRDX) have been struggling lately and have lost 5.1% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the...\n more…
Zacks Investment Research A downtrend has been apparent in SurModics (SRDX) lately with too much selling pressure. The stock has declined 5.5% over the past four weeks. However, given the fact that it is now in oversold...\n more…
Zacks Investment Research SurModics (SRDX) has been on a downward spiral lately with significant selling pressure. After declining 6.3% over the past four weeks, the stock looks well positioned for a trend reversal as it is...\n more…
Seeking Alpha - Healthcare Surmodics merger deal draws FTC second request...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nSRDX stock results show that Surmodics beat analyst estimates for earnings per share and beat on revenue for the third quarter of...\n more…